Edwin Kolp
About Edwin Kolp
Edwin Kolp is a Protocol Manager at Syneos Health, currently working at Bristol-Myers Squibb in New York. He has extensive experience in managing investigator-sponsored research and Phase IV trials.
Current Role at Syneos Health
Edwin Kolp is currently the Protocol Manager for Investigator Sponsored Research and Phase IV Trials at Syneos Health, stationed in New York, New York. In this role, he oversees the management and coordination of clinical trials, ensuring that they comply with regulatory standards and Sponsor requirements. He provides support for the design, implementation, and monitoring of research protocols, fostering effective communication between investigators, sites, and sponsors.
Previous Experience at GSK
Edwin Kolp worked as a Laboratory Study Manager at GSK from 2010 to 2017. During his seven-year tenure, he was responsible for managing laboratory studies, which included planning, execution, and reporting of study results. His role required collaboration with cross-functional teams to ensure the smooth operation of laboratory processes and adherence to Good Laboratory Practices (GLPs).
Role at Henogen
From 2008 to 2010, Edwin Kolp served as a Clinical Trial Assistant at Henogen. In this role, he supported the coordination of clinical trials, facilitating communication between clinical sites and the sponsor. His responsibilities included documentation management, monitoring trial progress, and ensuring compliance with regulatory standards.
Early Career at CHU UCL Namur
Edwin Kolp's early career included a position as a Laboratory Technician at CHU UCL Namur, where he worked from 2004 to 2008. In this position, he was involved in the preparation and execution of laboratory experiments, maintenance of laboratory equipment, and data collection. This role provided him with foundational experience in laboratory practices and research methodologies.
Educational Background
Edwin Kolp holds a Bachelor of Science degree, earned between 2002 and 2004. He attended the International College of Aromatherapy in 2014 and the International School of Choueifat in 1999. These diverse educational experiences have contributed to his knowledge base in clinical research and laboratory management.